General Administration of Market Supervision: For-profit medical institutions shall not use the name "Xiehe" without authorization

  Yesterday, the Beijing Youth Daily reporter learned from the General Administration of Market Supervision that the bureau recently held a system-wide video and telephone conference and issued a notice, requiring the system-wide to take the initiative, implement responsibilities, and carry out actions to resolutely clean up and rectify counterfeit problems in well-known hospitals, and verify one by one in the name For-profit medical institutions (including enterprises, individual industrial and commercial households, the same below) that use well-known hospital names such as "Concord", "Huashan", "Tongji", "Huaxi", "Xiangya", "Qilu", and "Tongren" will be severely punished for disrupting the order of the medical market Illegal behavior.

  Well-known hospitals have won social credibility and public praise due to their medical strength, but some medical institutions used well-known hospital names such as "Xiehe" without legal authorization to defraud and mislead the people, and endanger patients in medical activities Health has seriously violated the legal rights and public image of regular hospitals, and disrupted the normal medical order.

In response, the society has responded strongly.

  The market supervision department cleans up and rectifies the counterfeit problem of well-known hospitals, in an attitude of being responsible for the life safety and health of the people, further intensify its work, thoroughly investigate the counterfeit problem of well-known hospitals, and build a safety barrier for people’s lives and health. .

  The General Administration of Market Supervision requires that market entities with well-known hospital names should be thoroughly cleaned up.

All for-profit medical institutions that have not applied for medical institution licenses or inconsistent licenses and licenses shall be ordered to change their names; for for-profit medical institutions and enterprises in related industries such as hospital management, medical cosmetology, and drugs, their names may deceive or misunderstand the public in use 1. Anyone who damages the lawful rights and interests of others shall be corrected according to law.

For-profit medical institutions other than well-known hospitals, without the direct authorization of the right holder, shall not use well-known hospital names such as "Xiehe" in their names.

  The focus of this clean-up and rectification is to investigate and punish illegal acts.

Severely crack down on unfair competition and price violations in the medical field, severely crack down on the publication of false and illegal medical advertisements, and severely crack down on trademark infringement and illegal activities of medical institutions.

Focus on investigating and punishing the name of the company that violates the relevant provisions of the Anti-Unfair Competition Law, misleading people to believe that it is a product of a well-known hospital or has a specific connection with a well-known hospital; intensify efforts to combat the unauthorized use of well-known hospital name signs such as "Xiehe" by medical institutions, or Use illegal names to publish false advertisements, deceive and induce patients, exaggerate the condition or curative effect; strengthen the protection of the trademark rights of well-known hospitals.

  The General Administration of Market Supervision requires that the credit supervision of for-profit medical institutions be strengthened, and relevant administrative penalties, spot checks and inspection results of for-profit medical institutions and other market entities shall be disclosed to the society through the national enterprise credit information publicity system in a timely manner in accordance with laws and regulations to strengthen credit punishment . At the same time, strengthen coordination and communication with health departments and establish a long-term mechanism for brand protection of well-known hospitals. Text/Reporter Lin Lishuang